← Back
Data updated: Mar 10, 2026
SINOTHERAPEUTICS INC
ImmunologyGastroenterologyCardiovascular
SINOTHERAPEUTICS INC is a generic drug manufacturer focused on Immunology, Gastroenterology, Cardiovascular.
2017
Since
7
Drugs
-
Trials
155
Approved (2yr)
Recent Activity
BUPROPION HYDROCHLORIDE 2026-02-25
Labeling
TOFACITINIB CITRATE 2026-02-18
Labeling
TOFACITINIB CITRATE 2026-02-18
Labeling
TOFACITINIB CITRATE 2026-02-18
Labeling
TOFACITINIB CITRATE 2026-02-18
Labeling
TOFACITINIB CITRATE 2026-02-18
Labeling
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 2025-12-02
TOFACITINIB CITRATE 2025-11-17
BUPROPION HYDROCHLORIDE 2025-11-06
Labeling
BUPROPION HYDROCHLORIDE 2025-11-06
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 70%
1 drugs Phase 3: 5 Phase 2: 3
Gastroenterology 13%
1 drugs
Cardiovascular 13%
1 drugs
Dermatology 4%
0 drugs Phase 2: 1
Pipeline Strength Pro
Loading...
Competitors Pro
BAUSCH specialty
Dermatology, Immunology, Cardiovascular, Gastroenterology
Pfizer big-pharma
Dermatology, Immunology, Gastroenterology
COREPHARMA other
Cardiovascular, Immunology, Gastroenterology, Dermatology
COSETTE other
Cardiovascular, Dermatology, Immunology
BAUSCH AND LOMB specialty
Cardiovascular, Dermatology, Immunology
Active (3)
Discontinued (2)
Company Info
- First Approval
- 2017-08-21
- Latest
- 2025-09-30
- Applications
- 7